Givaudan Active Beauty is continuing its investments in skin microbiome research. The company has acquired a new automatized equipment for high speed genomic screening with the aim to accelerate the development of innovative cosmetic ingredients designed to activate, protect or balance the skin microbiota.
Givaudan continues to invest in its Active Beauty business unit and its metagenomics platform to boost its pioneering position in the microbiome market. Givaudan, which claims to be the only fragrance company with in-house microbiome research capabilities, says these new strategic investments will help the company to remain one of the leaders in the development of new actives focusing on the skin microbiome.
Kristel Adriaenssens Milet 1 April 2025 Social intelligence company Dynvibe, which specialises in behavioural marketing…
26 March 2025 The 35th IFSCC Congress will take place in Cannes from September 15…
This AI-powered skin diagnostic device uses bio-optical technology alongside AI algorithms to analyze the skin’s…